Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Cell and gene therapies, while still affecting a small number of patients, can carry per-treatment costs exceeding $500,000, creating catastrophic claims risk that disproportionately impacts smaller employer groups with less capacity to absorb outlier costs
Trusted pharmaceutical-grade formulation
The interaction between the Gly-His-Lys peptide and fibroblasts is believed to potentially initiate a cascade of biological events leading to the synthesis of collagen, thereby playing a potential role in the mechanisms of tissue repair and regeneration
Adherence plays a practical role as well
US$ 20.75
US$ 26.77
US$ 24.80
